Presentation is loading. Please wait.

Presentation is loading. Please wait.

Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial.

Published byΣταύρος Αναστασιάδης Modified over 5 years ago

Similar presentations

Presentation on theme: "Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial."— Presentation transcript:

1 Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions  Frank J. Veith, M.D., Sushil K. Gupta, M.D., Enrico Ascer, M.D., Sheila White-Flores, B.S.N., Russell H. Samson, M.D., Larry A. Scher, M.D., Jonathan B. Towne, M.D., Victor M. Bernhard, M.D., Patricia Bonier, R.N., William R. Flinn, M.D., Patricia Astelford, R.N., James S.T. Yao, M.D., Ph.D., John J. Bergan, M.D.  Journal of Vascular Surgery  Volume 3, Issue 1, Pages (January 1986) DOI: / (86)90073-X Copyright © 1986 Society for Vascular Surgery and North American Chapter, International Society for Cardiovascular Surgery Terms and Conditions

2 Fig. 1 Cumulative life-table primary patency rates for all randomized bypasses performed to popliteal artery with autologous saphenous vein (ASV) and polytetrafluoroethylene (PTFE) grafts. Number with each point indicates number of patent grafts observed for that length of time. Standard error of each point is shown. Journal of Vascular Surgery 1986 3, DOI: ( / (86)90073-X) Copyright © 1986 Society for Vascular Surgery and North American Chapter, International Society for Cardiovascular Surgery Terms and Conditions

3 Fig. 2 Cumulative life-table primary patency rates for all randomized autologous saphenous vein (ASV) and polytetrafluoroethylene (PTFE) bypass performed to popliteal artery (A), above-knee; (B), below-knee. Number with each point indicates number of patent grafts observed for that length of time. Standard error of each point is shown. Journal of Vascular Surgery 1986 3, DOI: ( / (86)90073-X) Copyright © 1986 Society for Vascular Surgery and North American Chapter, International Society for Cardiovascular Surgery Terms and Conditions

4 Fig. 3 Cumulative life-table limb salvage rates for all patients with randomized autologous saphenous vein (ASV) and polytetrafluoroethylene (PTFE) grafts to popliteal artery. All operations represented here were performed to control critical ischemia. Number with each point indicates number of operated limbs observed to be intact for that length of time. Standard error of each point is shown. Journal of Vascular Surgery 1986 3, DOI: ( / (86)90073-X) Copyright © 1986 Society for Vascular Surgery and North American Chapter, International Society for Cardiovascular Surgery Terms and Conditions

5 Fig. 4 Cumulative life-table primary patency rates for all randomized bypasses to infrapopliteal arteries with autologous saphenous vein (ASV) and polytetrafluoroethylene (PTFE) grafts. Number with each point indicates number of grafts observed to be patent for that length of time. Standard error of each point is shown. Journal of Vascular Surgery 1986 3, DOI: ( / (86)90073-X) Copyright © 1986 Society for Vascular Surgery and North American Chapter, International Society for Cardiovascular Surgery Terms and Conditions

6 Fig. 5 Cumulative life-table limb salvage rates for patients with randomized autologous saphenous vein (ASV) and polytetrafluoroethylene (PTFE) grafts to infrapopliteal arteries. All operations represented here were performed to control critical ischemia. Number with each point indicates number of operated limbs observed to be intact for that length of time. Standard error of each point is shown. Journal of Vascular Surgery 1986 3, DOI: ( / (86)90073-X) Copyright © 1986 Society for Vascular Surgery and North American Chapter, International Society for Cardiovascular Surgery Terms and Conditions

7 Fig. 6 Cumulative life-table primary patency rates for all randomized and obligatory polytetrafluoroethylene (PTFE) bypasses to popliteal artery. Number with each point represents number of patent grafts observed for that length of time. Standard error of each point is shown. Journal of Vascular Surgery 1986 3, DOI: ( / (86)90073-X) Copyright © 1986 Society for Vascular Surgery and North American Chapter, International Society for Cardiovascular Surgery Terms and Conditions

Download ppt "Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial."

Similar presentations

Jeffrey P. Carpenter, MD, John E. Tomaszewski, MD 

Jeffrey P. Carpenter, MD, John E. Tomaszewski, MD 
A review of 100 consecutive reconstructions of the distal vertebral artery for embolic and hemodynamic disease  Ramon Berguer, MD, PhD, Mark D. Morasch,

A review of 100 consecutive reconstructions of the distal vertebral artery for embolic and hemodynamic disease  Ramon Berguer, MD, PhD, Mark D. Morasch,
Antiplatelet drugs in femoropopliteal vein bypasses: A multicenter trial  Charles McCollum, MB, ChB, MD, FRCS, Christine Alexander, Dip N, Glenda Kenchington,

Antiplatelet drugs in femoropopliteal vein bypasses: A multicenter trial  Charles McCollum, MB, ChB, MD, FRCS, Christine Alexander, Dip N, Glenda Kenchington,
Richard M. Green, MD, William M

Richard M. Green, MD, William M
Tibiotibial vein bypass grafts: A new operation for limb salvage

Tibiotibial vein bypass grafts: A new operation for limb salvage
Result of bypass grafting for upper limb ischemia

Result of bypass grafting for upper limb ischemia
Enrico Ascer, MD, Frank J. Veith, MD, Sushil K. Gupta, MD 

Enrico Ascer, MD, Frank J. Veith, MD, Sushil K. Gupta, MD 
Jeffrey P. Carpenter, MD, John E. Tomaszewski, MD 

Jeffrey P. Carpenter, MD, John E. Tomaszewski, MD 
Lloyd M. Taylor, M.D., Edward S. Phinney, M.D., John M. Porter, M.D. 

Lloyd M. Taylor, M.D., Edward S. Phinney, M.D., John M. Porter, M.D. 
Pedal bypass versus tibial bypass with autogenous vein: A comparison of outcome and hemodynamic results  Joseph R. Schneider, MD, PhD, Daniel B. Walsh,

Pedal bypass versus tibial bypass with autogenous vein: A comparison of outcome and hemodynamic results  Joseph R. Schneider, MD, PhD, Daniel B. Walsh,
Nontraumatic mesenteric vascular emergencies

Nontraumatic mesenteric vascular emergencies
Impact of a critical pathway on postoperative length of stay and outcomes after infrainguinal bypass  Andrew C. Stanley, MD, Maryann Barry, RN, Thayer.

Impact of a critical pathway on postoperative length of stay and outcomes after infrainguinal bypass  Andrew C. Stanley, MD, Maryann Barry, RN, Thayer.
Jeffrey P. Carpenter, MD, John E. Tomaszewski, MD 

Jeffrey P. Carpenter, MD, John E. Tomaszewski, MD 
Surgical treatment of venous obstruction and insufficiency

Surgical treatment of venous obstruction and insufficiency
Axillofemoral bypass: A tool with a limited role

Axillofemoral bypass: A tool with a limited role
Percutaneous transluminal angioplasty for the treatment of limb threatening ischemia: Do the results justify an attempt before bypass grafting?  Richard.

Percutaneous transluminal angioplasty for the treatment of limb threatening ischemia: Do the results justify an attempt before bypass grafting?  Richard.
Return to well-being and function after infrainguinal revascularization  Gary W. Gibbons, MD, Anne M. Burgess, RN, Edward Guadagnoli, PhD, Frank B. Pomposelli,

Return to well-being and function after infrainguinal revascularization  Gary W. Gibbons, MD, Anne M. Burgess, RN, Edward Guadagnoli, PhD, Frank B. Pomposelli,
Axillopopliteal bypass for limb salvage

Axillopopliteal bypass for limb salvage
Edmond J. Prendiville, MB, FRCSI, Anson Yeager, MD, Thomas F

Edmond J. Prendiville, MB, FRCSI, Anson Yeager, MD, Thomas F
Early complications and long-term outcome after open surgical treatment of popliteal artery aneurysms: Is exclusion with saphenous vein bypass still the.

Early complications and long-term outcome after open surgical treatment of popliteal artery aneurysms: Is exclusion with saphenous vein bypass still the.

Similar presentations

Ads by Google